Bethany Sensenig 9 Meters Biopharma, Inc. (NMTR) insider trading activity

NMTR Quotes by TradingView

Bethany Sensenig is Chief Financial Officer of 9 METERS BIOPHARMA, INC.. Currently has a direct ownership of 41,077 shares of NMTR, which is worth approximately $821. The most recent transaction as insider was on Apr 21, 2023, when has been sold 9,100 shares (Common Stock) at a price of $1.21 per share, resulting in proceeds of $11,011. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.1K
0% 3M change
0% 12M change
Total Value Held $821

Bethany Sensenig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 21 2023
SELL
Open market or private sale
$11,011 $1.21 p/Share
9,100 Reduced 18.14%
41,077 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
50,177 Added 50.0%
50,177 Common Stock

Also insider at

SUPN
SUPERNUS PHARMACEUTICALS, INC. Healthcare
Director
KALV
KalVista Pharmaceuticals, Inc. Healthcare
BS

Bethany Sensenig

Chief Financial Officer
Raleigh, NC

Track Institutional and Insider Activities on NMTR

Follow 9 METERS BIOPHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTR shares.

Notify only if

Insider Trading

Get notified when an 9 Meters Biopharma, Inc. insider buys or sells NMTR shares.

Notify only if

News

Receive news related to 9 METERS BIOPHARMA, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NMTR